654
Views
36
CrossRef citations to date
0
Altmetric
Review

Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis

, , , &
Pages 649-657 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fabiola Atzeni, Maria Chiara Gerardi, Giuseppe Barilaro, Ignazio Francesco Masala, Maurizio Benucci & Piercarlo Sarzi-Puttini. (2018) Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review. Expert Review of Clinical Immunology 14:1, pages 69-82.
Read now

Articles from other publishers (35)

Loris Riccardo Lopetuso, Claudia Cuomo, Irene Mignini, Antonio Gasbarrini & Alfredo Papa. (2023) Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases. International Journal of Molecular Sciences 24:9, pages 8187.
Crossref
Kenji Onda, Takeshi Honma & Koichi Masuyama. (2023) Methotrexate-related adverse events and impact of concomitant treatment with folic acid and tumor necrosis factor-alpha inhibitors: An assessment using the FDA adverse event reporting system. Frontiers in Pharmacology 14.
Crossref
Jessica Fairley & Indi Rasaratnam. 2023. Beyond Evidence-Based Medicine. Beyond Evidence-Based Medicine 479 482 .
Emily C. Bartlett, Elizabeth A. Renzoni, Nishanth Sivarasan & Sujal R. Desai. (2022) Imaging of Lung Disease Associated with Connective Tissue Disease. Seminars in Respiratory and Critical Care Medicine 43:06, pages 809-824.
Crossref
Lorenzo Cereser, Emanuele Passarotti, Alessandro De Pellegrin, Vincenzo Patruno, Emma Di Poi, Filippo Marchesini, Chiara Zuiani & Rossano Girometti. (2022) Chest high-resolution computed tomography in patients with connective tissue disease: pulmonary conditions beyond “the usual suspects”. Current Problems in Diagnostic Radiology 51:5, pages 759-767.
Crossref
Cristhian Emilio Herrera Céspedes, Catalina González Avilés, Olga Milena García Morales & Pierangely Prieto Campos. (2022) Neumonitis por metotrexato en artritis reumatoidea: presentación de un caso. Universitas Médica 63:2.
Crossref
Evangelia Zampeli & Kyriaki Gerasimidou. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 427 446 .
Emine Atağ, Zeynep Seda Uyan & Refika Ersu. 2022. Pediatric ENT Infections. Pediatric ENT Infections 311 332 .
Carlos Fernández-Díaz, Belén Atienza-Mateo, Santos Castañeda, Rafael B Melero-Gonzalez, Francisco Ortiz-SanJuan, Javier Loricera, Ivette Casafont-Solé, Sebastián Rodríguez-García, Clara Aguilera-Cros, Ignacio Villa-Blanco, Enrique Raya-Alvarez, Clara Ojeda-García, Gema Bonilla, Alejandra López-Robles, Luis Arboleya, Javier Narváez, Evelin Cervantes, Olga Maiz, María N Alvarez-Rivas, Iván Cabezas, Eva Salgado, Cristina Hidalgo-Calleja, Sabela Fernández, Jesús C Fernández, Ivan Ferraz-Amaro, Miguel A González-Gay & Ricardo Blanco. (2022) Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis—multicentre study of 263 Caucasian patients . Rheumatology 61:1, pages 299-308.
Crossref
Theodoros Karampitsakos, Ourania Papaioannou, Fotios Sampsonas & Argyrios Tzouvelekis. (2021) Infliximab-induced interstitial lung disease. BMJ Case Reports 14:10, pages e245726.
Crossref
Julie K. Dawson, Edmond Quah, Ben Earnshaw, Constanta Amoasii, Tareg Mudawi & Lisa G. Spencer. (2021) Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review. Rheumatology International 41:6, pages 1055-1064.
Crossref
Liubov A. Ponomareva, Daria V. Gurova, Elena N. Popova, Natalia V. Chebotareva, Inna B. Bondarenko & Sergey V. Moiseev. (2021) Methotrexate-induced lung damage in a patient with rheumatoid arthritis. Terapevticheskii arkhiv 93:3, pages 295-299.
Crossref
Mohamed Faisal, Asyraf Roslan, Nik Nuratiqah Nik Abeed & Andrea Ban Yu-Lin. (2021) Disease-modifying antirheumatic drugs and organising pneumonia. BMJ Case Reports 14:1, pages e238173.
Crossref
Lin-qin Wang, Elaine Tan Su Yin, Guo-qing Wei, Yong-xian Hu, Arnon Nagler & He Huang. (2020) Weathering the storm: COVID-19 infection in patients with hematological malignancies应对恶性血液肿瘤在新型冠状病毒肺炎疫情中的挑战. Journal of Zhejiang University-SCIENCE B 21:12, pages 921-939.
Crossref
Shamma Ahmad Al Nokhatha, Robert Harrington & Richard Conway. (2020) Methotrexate and The Lung in Rheumatoid Arthritis. EMJ Rheumatology, pages 80-90.
Crossref
George E Fragoulis, Richard Conway & Elena Nikiphorou. (2019) Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature. Rheumatology 58:11, pages 1900-1906.
Crossref
George E. Fragoulis, Elena Nikiphorou, Jörg Larsen, Peter Korsten & Richard Conway. (2019) Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment. Frontiers in Medicine 6.
Crossref
Benedetto Caroleo, Alberto Migliore, Erika Cione, Stefania Zampogna, Francesco Perticone, Giovambattista De Sarro & Luca Gallelli. (2019) Double Infection in a Patient with Psoriatic Arthritis Under TNF-alpha Blockers Therapy: A Case Report. Current Drug Safety 14:2, pages 147-150.
Crossref
Peter. C. Taylor, Alejandro Balsa Criado, Anne-Barbara Mongey, Jerome Avouac, Hubert Marotte & Rudiger B. Mueller. (2019) How to Get the Most from Methotrexate (MTX) Treatment for Your Rheumatoid Arthritis Patient?—MTX in the Treat-to-Target Strategy. Journal of Clinical Medicine 8:4, pages 515.
Crossref
Theodoros Karampitsakos, Argyro Vraka, Demosthenes Bouros, Stamatis-Nick Liossis & Argyris Tzouvelekis. (2019) Biologic Treatments in Interstitial Lung Diseases. Frontiers in Medicine 6.
Crossref
Jesse Wolfe, Joshua Wolfe & H. John Visser. (2019) Perioperative Management of the Rheumatoid Patient. Clinics in Podiatric Medicine and Surgery 36:1, pages 115-130.
Crossref
Seema Alaee & Quentin Jones. (2018) Case of drug-induced interstitial lung disease secondary to adalimumab. Drug and Therapeutics Bulletin 56:12, pages 150-153.
Crossref
Seema Alaee & Quentin Jones. (2018) Case of drug-induced interstitial lung disease secondary to adalimumab. BMJ Case Reports, pages bcr-2018-224375.
Crossref
Meghna Jani, William G. Dixon & Eric L. Matteson. 2018. Lung Disease in Rheumatoid Arthritis. Lung Disease in Rheumatoid Arthritis 121 161 .
Michal Cidon, Manvi Bansal & Dominik Hartl. (2017) Pulmonary manifestations of rheumatologic diseases. Current Opinion in Pediatrics 29:3, pages 311-319.
Crossref
Li-Ta Keng, Mong-Wei Lin, Hsien-Neng Huang & Kuei-Pin Chung. (2016) Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment. Medicine 95:26, pages e4044.
Crossref
Ayse Balkarli & Veli Cobankara. (2016) Pulmonary Nodulosis Associated with Leflunomide Therapy in Rheumatoid Arthritis: Report of Four Cases and Review of the Literature. Journal of Clinical and Experimental Investigations 7:1.
Crossref
Elías Forero, Monique Chalem, Gloria Vásquez, Edwin Jauregui, Luis Fernando Medina, Luis Fernando Pinto Peñaranda, John Medina, Yimy Medina, Diego Jaimes, Ana Milena Arbelaez, Aura María Domínguez, Andrés Fernández, Oscar Jair Felipe-Díaz, Philippe Chalem, Carlo Vinicio Caballero Uribe, María José Jannaut, Ixhel García, Wilson Bautista, Javier Ramírez Figueroa, Jorge Cortés, Jorge Quintero & Nohora Rodríguez. (2016) Risk management for prescribing biological therapies. Revista Colombiana de Reumatología (English Edition) 23:1, pages 50-67.
Crossref
Elías Forero, Monique Chalem, Gloria Vásquez, Edwin Jauregui, Luis Fernando Medina, Luis Fernando Pinto Peñaranda, John Medina, Yimy Medina, Diego Jaimes, Ana Milena Arbelaez, Aura María Domínguez, Andrés Fernández, Oscar Jair Felipe-Díaz, Philippe Chalem, Carlo Vinicio Caballero Uribe, María José Jannaut, Ixhel García, Wilson Bautista, Javier Ramírez Figueroa, Jorge Cortés, Jorge Quintero & Nohora Rodríguez. (2016) Gestión de riesgo para la prescripción de terapias biológicas. Revista Colombiana de Reumatología 23:1, pages 50-67.
Crossref
Gilberto Toshikawa Yoshikawa, George Alberto da Silva Dias, Satomi Fujihara, Luigi Ferreira e Silva, Lorena de Britto Pereira Cruz, Hellen Thais Fuzii & Roberta Vilela Lopes Koyama. (2015) Formation of multiple pulmonary nodules during treatment with leflunomide. Jornal Brasileiro de Pneumologia 41:3, pages 281-284.
Crossref
Zulma X. Yunt & Joshua J. Solomon. (2015) Lung Disease in Rheumatoid Arthritis. Rheumatic Disease Clinics of North America 41:2, pages 225-236.
Crossref
Takafumi Suda. (2016) Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23289.
Crossref
Hiroshi KitazawaShigeo Kure. (2015) Interstitial Lung Disease in Childhood: Clinical and Genetic Aspects. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23282.
Crossref
Matteo Filippini, Chiara Bazzani, Fabiola Atzeni, Piercarlo Sarzi Puttini, Antonio Marchesoni, Ennio Giulio Favalli, Roberto Caporali, Lorenzo Cavagna & Roberto Gorla. (2014) Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry. BioMed Research International 2014, pages 1-8.
Crossref
Toby M. Maher. 2014. Pulmonary Manifestations of Rheumatic Disease. Pulmonary Manifestations of Rheumatic Disease 193 216 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.